What is SonoMotion?
SonoMotion operates as a specialized medical device innovator focused on the development of non-invasive therapeutic solutions for kidney stone treatment. By prioritizing patient comfort and procedural efficiency, the company addresses critical gaps in traditional urological care. Its market position is defined by a commitment to technological advancement, aiming to disrupt standard lithotripsy practices with safer, more accessible alternatives. As a key player in the MedTech sector, SonoMotion integrates engineering precision with clinical necessity to improve patient outcomes globally.
How much funding has SonoMotion raised?
SonoMotion has raised a total of $27.2M across 4 funding rounds:
Series A
$4.6M
Series B
$10M
Debt
$179K
Series C
$12.4M
Series A (2017): $4.6M, investors not publicly disclosed
Series B (2019): $10M, investors not publicly disclosed
Debt (2021): $179K supported by PPP
Series C (2022): $12.4M featuring Advanced MedTech Holdings
Key Investors in SonoMotion
Advanced MedTech Holdings
Advanced MedTech Holdings is a global leader in urological stone treatment, backed by Temasek Holdings, and focused on transforming care through integrated medical device innovation.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for SonoMotion?
With the recent infusion of capital, SonoMotion is expected to prioritize the commercialization of its core technology and the expansion of its clinical trial infrastructure. The strategic alignment with industry leaders suggests a focus on scaling manufacturing capabilities and navigating regulatory pathways for broader market adoption. Future growth will likely center on enhancing the efficacy of its non-invasive platforms, potentially exploring new applications within prostate health and robotic-assisted urology. As the company transitions into this next phase of maturity, the emphasis will remain on maintaining its competitive edge through rigorous research and development, ensuring that its solutions remain at the forefront of the urological care market.
See full SonoMotion company page
